CEVA BREAKS THE BILLION EURO BARRIER FOR THE FIRST TIME >
Press conference held in Paris with Marc Prikazsky, Chief Executive Officer of Ceva Sante Animalé.
Double-digit growth for Ceva. >
Ceva continues to deliver double-digit growth, sales up 20% versus S1 2016 driven by organic growth and acquisitions.
EAGLES PRIDE HATCHERY KOSTER 2 - The proud winner of the CEVA Hatchery of the Year 2016 challenge >
EAGLES PRIDE HATCHERY KOSTER 2 wins Ceva’s 2nd Hatchery of the Year challenge. Eagles Pride made a clean sweep of the prizes as they boast three hatcheries in the top 5!
C.H.I.C.K Program: Hatchery Vaccination is now Quality Approved >
Ceva South Africa’s C.H.I.C.K Program has been awarded the first quality code of practice recognition from Bureau Veritas.
Ceva records double digit growth for 3rd. successive year >
14% growth pushes sales beyond 600 M€ for first time Libourne, France, 7 February, 2013:
New Technology Vaccine Symposium – Miami >
12 April 2013 Ceva shares global field experiences through New Technology Vaccine Symposium held in the US. Innovation in the hatchery will drive productivity gains
Ceva creates 60 strong teams to support innovative vaccination services on farm and in the hatchery >
29 April 2013 Recent research showed Ceva that their customers want more than just good vaccines; they want 100% of their birds correctly vaccinated.
2013 reprodAction Scientific Meeting - April 16-17th >
“Management and reproduction of dairy heifers” May 2013, Libourne - France
Ceva signs a Joint-venture agreement in China to help control zoonoses >
Joint-venture with Jinyu Baoling will produce brucellosis vaccines in Inner Mongolia Libourne 13th June 2013,
Ceva presents a complete range of vector vaccines at IPE 2013 >
25 January 2013 Vectormune® ND and Transmune® IBD, “The Perfect Pair” of vaccines for Gumboro and Newcastle prevention can now be administered in one injection at the hatchery.